Health Care·Health Care Equipment·$23.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.04 | N/A | +44.44% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.04 | N/A | +44.44% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management remains focused on innovation and expanding market reach. They acknowledged short-term hurdles but are optimistic about future prospects.
Management highlighted ongoing investments in product development.
They expressed confidence in long-term growth despite current challenges.
Dexcom's earnings report shows a mixed performance, with a smaller-than-expected loss per share. However, the lack of revenue details and no guidance contributed to a negative stock reaction, with shares falling 2.47%. Investors may be cautious as the company navigates current challenges while focusing on long-term growth strategies.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
MEDTRONIC PLC
Feb 18, 2014